Christina Alcorn
Psychiatric/Mental Health · Middletown, OHNPI 1124809314
Payments from drug & device makers
Across 142 payments — averaging $16.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$739
- Axsome Therapeutics, Inc.$266
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$232
- Vanda Pharmaceuticals Inc.$196
- Alkermes, Inc.$196
- Otsuka America Pharmaceutical, Inc.$178
- plus $510 from 10 others
What the payments were for
- Food & beverage$2,314100%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 61 | $739 |
| Axsome Therapeutics, Inc. | 10 | $266 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $232 |
| Vanda Pharmaceuticals Inc. | 8 | $196 |
| Alkermes, Inc. | 16 | $196 |
| Otsuka America Pharmaceutical, Inc. | 10 | $178 |
| Teva Pharmaceuticals USA, Inc. | 6 | $123 |
| Neurocrine Biosciences, Inc. | 5 | $113 |
| Supernus Pharmaceuticals, Inc. | 5 | $93 |
| Lundbeck LLC | 2 | $43 |
| Sage Therapeutics, LLC | 2 | $41 |
| Tris Pharma Inc | 2 | $34 |
| Almatica Pharma LLC | 1 | $20 |
| Tempus AI, Inc | 1 | $16 |
| Johnson & Johnson | 1 | $14 |
| Neos Therapeutics, LP | 1 | $13 |
How this compares
$2,317 in reported general payments places this provider in the 75th percentile of 1,808 psychiatric/mental health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 28 | $38,723 |
| Mirtazapine | 14 | $267 |
| Quetiapine Fumarate | 16 | $128 |
| Alprazolam | 22 | $107 |
| Lamotrigine | 20 | $92 |
| Lorazepam | 18 | $86 |
| Clonazepam | 11 | $50 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $739 | $38,72328 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,808 psychiatric/mental health providers in Ohio.
Other psychiatric/mental health in Middletown
- Leslie HuntMiddletown$19K
- Lavinda McAuliffeMiddletown$12K
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Mary HallWarren$195K
- Kassandra KornbauCanfield$170K
- Terri PopovitzCincinnati$161K
- Steven MatesDayton$121K
- Robert ParsonsYoungstown$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.